Executive Team

Brian Lee, Ph.D.
CEO and Co-Founder

More than 25 years of research, management, and leadership experience in biopharmaceutical R&D, bioprocess scale up, and biomanufacturing with Amgen and Merck & Co.

Nelson Bermudez
Chief Operating Officer

More than 25 years of executive experience directing global operations and external contract manufacturing for biopharmaceutical drugs at Amgen.

Joe Petrosky
Senior VP of Global Sales and Marketing

More than 25 years of sales, marketing, and customer management experience with biotech single-use products at Charter Medical and Millipore Corporation.

Mark Schneider
VP of Finance & Corporate Controller

More than 25 years of accounting and financial planning management experience in both public and private biopharmaceutical companies including Amgen, Kythera, and Sienna.

Michael Murguia
VP of Human Resources

Over 35 years of HR management expertise such as talent acquisition, organizational development, and strategic planning at Amgen and various Fortune 100 companies.

Board of Directors

Brian Lee, Ph.D.
CEO & Chairman of the Board
Dennis Fenton, Ph.D.
Former Executive VP at Amgen.
Leland Foster, Ph.D.
Former Chief Scientific Officer at Thermo Fisher Scientific.
Jerry Liao
VP at Avego Management.
Bryan Poltilove
Operating Partner at BroadOak Capital and former VP at Thermo Fisher Scientific.

Advisory Board

Manuel Carrondo, Ph.D.
Former CEO of Instituto de Biologia Experimental Tecnologica (IBET) in Portugal.
Matthew Croughan, Ph.D.
Industry Professor and Former Director of Amgen Bioprocessing Center of KGI.
Steve Lam
Former VP and General Manager of Single-Use Technology at Thermo Fisher Scientific and VP of Operations at Amgen.
Susan Lundeen
Former VP of Human Resources at Amgen and Kythera Biopharmaceuticals.
Bill Rich
Former VP of Device Technologies, VP of External Supply, and VP of International Supply Chain at Amgen.
Martin Simonetti
Former President & CEO of VLST, CFO of Dendreon, and VP of Finance of Amgen.
Geoffrey Slaff, Ph.D.
Former Senior VP of Process Development, Operations, and Quality at Amgen.
Lourie Zak
Former Executive Director of Finance at Amgen.
B.G. Rhee, Ph.D.
Chairman and CEO of G.I. Innovations; former Chairman of Korea's Council for Advanced Regenerative Medicine.
Brent Reinke
Shareholder in the Corporate and Securities practice group at Stradling Yocca Carlson & Rauth.
Gregory Zeikus, Ph.D.
Former CEO of Michigan Biotechnology Institute; Professor Emeritus at MSU.